North East, MD, United States of America

Clene Nanomedicine, Inc.

Calculating rank

USPTO Granted Patents = 5

EPO Patents = 4

Forward Citations = 15

Loading Chart...

9 inventors (with patents filed for the assignee):

Mark Gordon Mortenson (5 out of 33 patents)

David Andrew Bryce (5 out of 14 patents)

David Kyle Pierce (3 out of 11 patents)

4. Mikhail Merzliakov (3 out of 8 patents)

5. D Kyle Pierce (2 out of 4 patents)

6. Reed N Wilcox (2 out of 25 patents)

7. Anthony Lockett (2 out of 3 patents)

8. Adam Robert Dorfman (1 out of 5 patents)

9. Arthur Maxwell Grace (1 out of 3 patents)

10. Zhongyan Zhang (0 patent)

11. David A Bryce (1 patent)

5 patents: Sort by Forward Citations

1. 10980832 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2021-04-20),

2. 10449217 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2019-10-22),

3. 10441608 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2019-10-15),

4. 10092007 - Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom (2018-10-09),

5. 10035192 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g.,nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2018-07-31),

Company Overview

Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company focused on developing novel nanotechnology-based therapeutics for neurodegenerative diseases. Their proprietary nanotechnology platform enables the creation of clean-surfaced and crystalline nanoparticles designed to target and treat various neurological disorders. Clene's lead product candidate, CNM-Au8, is being developed for the treatment of multiple sclerosis and other neurodegenerative diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#1 in North East, MD

#751 in Maryland

#51,644 in US

North East, MD, United States of America

Clene Nanomedicine, Inc.

Forward Citations = 15

9 inventors:

Mark Gordon Mortenson (5 out of 33 patents)

David Andrew Bryce (5 out of 14 patents)

David Kyle Pierce (3 out of 11 patents)

4. Mikhail Merzliakov (3 out of 8 patents)

5. D Kyle Pierce (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Clene Nanomedicine, Inc.. Retrieved from https://idiyas.com/company/clene-nanomedicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]